TwinBeech Capital’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-74,438
| Closed | -$654K | – | 914 |
|
|
2023
Q4 | $654K | Buy |
+74,438
| New | +$654K | 0.01% | 531 |
|
|
2023
Q3 | – | Sell |
-171,166
| Closed | -$4.33M | – | 946 |
|
|
2023
Q2 | $4.33M | Buy |
171,166
+72,482
| +73% | +$1.83M | 0.09% | 263 |
|
|
2023
Q1 | $3.18M | Sell |
98,684
-68,798
| -41% | -$2.22M | 0.06% | 309 |
|
|
2022
Q4 | $3.09M | Buy |
+167,482
| New | +$3.09M | 0.06% | 351 |
|